ALXN
Fidelity Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,029,557
| Closed | -$740M | – | 5376 |
|
|
2021
Q2 | $740M | Buy |
4,029,557
+501,470
| +14% | +$92.1M | 0.06% | 310 |
|
|
2021
Q1 | $539M | Sell |
3,528,087
-2,756,438
| -44% | -$421M | 0.05% | 408 |
|
|
2020
Q4 | $982M | Sell |
6,284,525
-3,507,922
| -36% | -$548M | 0.09% | 211 |
|
|
2020
Q3 | $1.12B | Sell |
9,792,447
-3,208,004
| -25% | -$367M | 0.11% | 159 |
|
|
2020
Q2 | $1.46B | Buy |
13,000,451
+1,117,179
| +9% | +$125M | 0.16% | 114 |
|
|
2020
Q1 | $1.07B | Sell |
11,883,272
-2,809,110
| -19% | -$252M | 0.15% | 127 |
|
|
2019
Q4 | $1.59B | Sell |
14,692,382
-4,902,148
| -25% | -$530M | 0.18% | 108 |
|
|
2019
Q3 | $1.92B | Sell |
19,594,530
-5,991,461
| -23% | -$587M | 0.23% | 80 |
|
|
2019
Q2 | $3.35B | Sell |
25,585,991
-3,558,329
| -12% | -$466M | 0.39% | 39 |
|
|
2019
Q1 | $3.94B | Buy |
29,144,320
+2,746,055
| +10% | +$371M | 0.47% | 32 |
|
|
2018
Q4 | $2.57B | Buy |
26,398,265
+5,301,272
| +25% | +$516M | 0.35% | 48 |
|
|
2018
Q3 | $2.93B | Buy |
21,096,993
+1,581,376
| +8% | +$220M | 0.33% | 45 |
|
|
2018
Q2 | $2.42B | Buy |
19,515,617
+225,688
| +1% | +$28M | 0.28% | 54 |
|
|
2018
Q1 | $2.15B | Buy |
19,289,929
+1,615,805
| +9% | +$180M | 0.26% | 66 |
|
|
2017
Q4 | $2.11B | Sell |
17,674,124
-1,284,809
| -7% | -$154M | 0.25% | 71 |
|
|
2017
Q3 | $2.66B | Sell |
18,958,933
-2,415,344
| -11% | -$339M | 0.32% | 51 |
|
|
2017
Q2 | $2.6B | Sell |
21,374,277
-5,627,122
| -21% | -$685M | 0.32% | 51 |
|
|
2017
Q1 | $3.27B | Sell |
27,001,399
-1,166,764
| -4% | -$141M | 0.42% | 36 |
|
|
2016
Q4 | $3.45B | Buy |
28,168,163
+3,338,382
| +13% | +$408M | 0.46% | 33 |
|
|
2016
Q3 | $3.04B | Buy |
24,829,781
+6,083,986
| +32% | +$746M | 0.41% | 42 |
|
|
2016
Q2 | $2.19B | Buy |
18,745,795
+2,002,085
| +12% | +$234M | 0.3% | 63 |
|
|
2016
Q1 | $2.33B | Buy |
16,743,710
+1,864,885
| +13% | +$260M | 0.32% | 56 |
|
|
2015
Q4 | $2.84B | Buy |
14,878,825
+358,224
| +2% | +$68.3M | 0.38% | 43 |
|
|
2015
Q3 | $2.27B | Sell |
14,520,601
-419,401
| -3% | -$65.6M | 0.32% | 50 |
|
|
2015
Q2 | $2.7B | Sell |
14,940,002
-4,736,915
| -24% | -$856M | 0.35% | 50 |
|
|
2015
Q1 | $3.41B | Sell |
19,676,917
-2,468,340
| -11% | -$428M | 0.43% | 37 |
|
|
2014
Q4 | $4.1B | Buy |
22,145,257
+2,043,255
| +10% | +$378M | 0.53% | 28 |
|
|
2014
Q3 | $3.33B | Buy |
20,102,002
+2,392,465
| +14% | +$397M | 0.45% | 37 |
|
|
2014
Q2 | $2.77B | Sell |
17,709,537
-2,971,616
| -14% | -$464M | 0.37% | 47 |
|
|
2014
Q1 | $3.15B | Buy |
20,681,153
+1,113,004
| +6% | +$169M | 0.44% | 39 |
|
|
2013
Q4 | $2.6B | Sell |
19,568,149
-372,199
| -2% | -$49.5M | 0.37% | 51 |
|
|
2013
Q3 | $2.32B | Buy |
19,940,348
+3,157,520
| +19% | +$367M | 0.35% | 52 |
|
|
2013
Q2 | $1.55B | Buy |
+16,782,828
| New | +$1.55B | 0.25% | 76 |
|